Skip Navigation


JAC Advance Access originally published online on December 3, 2007
Journal of Antimicrobial Chemotherapy 2008 61(2):436-441; doi:10.1093/jac/dkm460
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
61/2/436    most recent
dkm460v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Garnacho-Montero, J.
Right arrow Articles by Garcia-Garmendia, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garnacho-Montero, J.
Right arrow Articles by Garcia-Garmendia, J. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study

José Garnacho-Montero1,*, Carlos Ortiz-Leyba1, Inmaculada Herrera-Melero1, Teresa Aldabó-Pallás1, Aurelio Cayuela-Dominguez2, Juan A. Marquez-Vacaro1, Jesus Carbajal-Guerrero1 and Jose L. Garcia-Garmendia3

1 Intensive Care Unit, Hospital Universitario Virgen del Rocío, Sevilla, Spain 2 Supportive Research Unit, Hospital Universitario Virgen del Rocío, Sevilla, Spain 3 Intensive Care Unit,Hospital San Juan de Dios, Sevilla, Spain

Received 11 September 2007; returned 3 October 2007; revised 28 October 2007; accepted 31 October 2007


* Corresponding author. Tel: +34-955012235; Fax: +34-955012239; E-mail: jose.garnacho.sspa{at}juntadeandalucia.es or jgmrji{at}arrakis.es

Objectives: To determine the attributable mortality and excess length of stay (LOS) associated with the use of inadequate empirical antimicrobial therapy in patients with sepsis at admission to the intensive care unit (ICU).

Methods: A retrospective matched cohort study was performed using a prospectively collected database at a 40 bed general ICU at a university public hospital. Patients who received inadequate antimicrobial therapy at admission to the ICU (exposed) were matched with controls (unexposed) on the basis of origin of sepsis, inflammatory response at admission, surgical or medical status, hospital- or community-acquired sepsis, APACHE II score (±2 points) and age (±10 years). Clinical outcome was assessed by in-hospital mortality, and this analysis was also performed in those pairs without nosocomial infection in the ICU.

Results: Eighty-seven pairs were successfully matched. Fifty-nine exposed patients died [67.8% mortality (95% CI, 58.0–77.6%)] and 25 unexposed controls died [28.7% mortality (95% CI, 19.2–38.2%)] (P < 0.001). Excess in-hospital mortality was estimated to be 39.1%. The rate of nosocomial infection was significantly higher in patients with inadequate empirical therapy (16.1%) than in those treated empirically with adequate antibiotics (3.4%) (P = 0.013). Excess in-hospital mortality was 31.4% after excluding those 17 pairs that developed a nosocomial infection in the ICU. Inadequate antimicrobial therapy was associated with a significant increment in duration of hospitalization (15 days in surviving pairs).

Conclusions: Inadequate antimicrobial therapy at admission to the ICU with sepsis is associated with excess mortality and increases LOS.

Keywords: septic shock , mortality , length of stay , bacteraemia , initial antibiotic therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
A. P. MacGowan and on behalf of the BSAC Working Parties on Resistanc
Clinical implications of antimicrobial resistance for therapy
J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii105 - ii114.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.